SHAHAB A AKHTER
Pharmacy in Ann Arbor, MI

License number
Michigan 5315005123
Issued Date
Mar 8, 2001
Expiration Date
Jan 31, 2005
Category
Pharmacy
Type
CS - 3
Address
Address
Ann Arbor, MI 48109

Personal information

See more information about SHAHAB A AKHTER at radaris.com
Name
Address
Phone
Shahab A Akhter, age 57
772 Waymarket Dr, Ann Arbor, MI 48103
(734) 665-4534

Professional information

Shahab A Akhter Photo 1

Dr. Shahab A Akhter, Madison WI - MD (Doctor of Medicine)

Specialties:
Cardiac Surgery
Address:
600 Highland Ave, Madison 53792
(608) 263-1530 (Phone), (608) 265-8887 (Fax)
Madison Office
600 Highland Ave SUITE H4831, Madison 53792
(608) 263-6400 (Phone), (608) 890-7127 (Fax)
UNIVERSITY OF CHICAGO MEDICAL CENTER
5841 S Maryland Ave, Chicago 60637
(773) 702-9200 (Phone), (773) 702-3538 (Fax)
5841 S Maryland Ave, Chicago 60637
(773) 702-2500 (Phone), (773) 702-4187 (Fax)
1500 E Medical Center Dr, Ann Arbor 48109
Conditions:
Congestive Heart Failure, Heart Attack (Acute Myocardial Infarction)
Certifications:
General Surgery, 2011, Thoracic Cardiovascular Surgery, 2003
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
600 Highland Ave, Madison 53792
5841 S Maryland Ave, Chicago 60637
1500 E Medical Center Dr, Ann Arbor 48109
UNIVERSITY OF CHICAGO MEDICAL CENTER
5841 S Maryland Ave, Chicago 60637
Madison Office
600 Highland Ave SUITE H4831, Madison 53792
University Hospital
234 Goodman St, Cincinnati 45219
Education:
Medical School
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1993
Duke University Med Center
Graduated: 1994
Graduated: 2000
University Mich Med Center
Graduated: 2002


Shahab Akhter Photo 2

Intracellular Inhibitors Of Gq Protein Signaling

US Patent:
2002019, Dec 26, 2002
Filed:
Jul 12, 2002
Appl. No.:
10/193234
Inventors:
Walter Koch - Durham NC, US
Robert Lefkowitz - Durham NC, US
Shahab Akhter - Ann Arbor MI, US
Louis Luttrell - Durham NC, US
Howard Rockman - Chapel Hill NC, US
Assignee:
DUKE UNIVERSITY
International Classification:
A61K038/17, A61K048/00
US Classification:
514/012000, 514/044000
Abstract:
The present invention relates, in general, to myocardial hypertrophy and, in particular, to agents that inhibit cardiac Gq-coupled receptor signaling and to methods of inhibiting myocardial hypertrophy using same.